---
title: Pfizer Recalls Levoxyl Due to Subpotent Drug Issues
canonical: https://federalfeed.com/pfizer-recalls-levoxyl-due-to-subpotent-drug-issues/
published: '2026-11-02T18:12:26-05:00'
updated: '2026-11-02T18:12:26-05:00'
author: FederalFeed Staff
section: Medicine & Device Recalls
tags:
- FDA
source: Food and Drug Administration
source_url: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=99963
publisher: FederalFeed
attribution: Copyright FederalFeed. Quote with credit to FederalFeed and a link to the canonical URL above.
---

# Pfizer Recalls Levoxyl Due to Subpotent Drug Issues

The Food and Drug Administration announced a recall of Levoxyl (levothyroxine sodium tablets, USP) distributed by Pfizer Inc. on September 29, 2026. The recall affects tablets in 175 mcg, 100 tablet bottles and 1000-count bottles, due to a confirmed out-of-specification assay during stability testing.

This recall is classified as Class II, indicating it may cause temporary or reversible health problems, and is ongoing across the US and Puerto Rico. Details can be found in the [FDA's weekly enforcement report](https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=99963).

---

### Press Release: Food and Drug Administration

*Published October 28, 2026. Reproduced in full from the [Food and Drug Administration](https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=99963).*

#### Pfizer drug recall

- Recalling company: Pfizer
- Classification: Class II (may cause temporary or reversible health problems)
- Recall numbers: D-0051-2027, D-0052-2027
- Status: Ongoing
- Distribution: US Nationwide and Puerto Rico
- Recall started: September 29, 2026

#### What was recalled

Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-01.

Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-10

#### Why

Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.

This drug recall appears in the FDA's weekly enforcement report. Details: [FDA recall event 99963](https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=99963).

Source: [Food and Drug Administration](https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=99963)